Assessment of Risk Management Plan Impact on Physician, Pharmacist and Patient Knowledge
Assessment of Risk Management Plan Impact on Physician, Pharmacist and Patient Knowledge
1 PagesCASE STUDY: CLIENT SIZE THERAPEUTIC AREA GEOGRAPHY DISCOVERY / NONCLINICAL DISCOVERY / NONCLINICAL DISCOVERY / NON-CLINICAL DISCOVERY / NON-CLINICAL DISCOVERY / NON-CLINICAL CLINICAL DEVELOPMENT APPROVAL / AUTHORIZATION PRODUCT MAINTENANCE US Cardiovascular Large pharmaceutical Assessment of Risk Management Plan Impact on Physician, Pharmacist and Patient Knowledge CLIENT NEED OUR SOLUTION PHARMALEX VALUE TO CLIENT The client was a large pharmaceutical company with offices worldwide The company was launching a new phosphodiesterase type 5 (PDE-5) inhibitor for treatment of erectile dysfunction The drug class was previously associated with adverse events when used concomitantly with anti-hypertensives PharmaLex was contracted to develop methodology and assess the effectiveness o
